153 related articles for article (PubMed ID: 6169615)
1. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB
Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
[No Abstract] [Full Text] [Related]
2. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
3. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
[TBL] [Abstract][Full Text] [Related]
4. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
[TBL] [Abstract][Full Text] [Related]
5. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
Romeo F; Russo A; Liuzzo P
Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
[No Abstract] [Full Text] [Related]
6. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
[TBL] [Abstract][Full Text] [Related]
7. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
[TBL] [Abstract][Full Text] [Related]
8. Approaches to the treatment of chronic hepatitis B viral infection.
Thomas HC; Lok AS
Prog Clin Biol Res; 1983; 143():379-93. PubMed ID: 6199798
[TBL] [Abstract][Full Text] [Related]
9. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K
Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
[TBL] [Abstract][Full Text] [Related]
10. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
Omata M; Uchiumi K
J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
Infection; 1984; 12(4):248-50. PubMed ID: 6490167
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
Hafkin B; Pollard RB; Tiku ML; Robinson WS; Merigan TC
Antimicrob Agents Chemother; 1979 Dec; 16(6):781-7. PubMed ID: 533259
[TBL] [Abstract][Full Text] [Related]
13. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
Guerre J; Gaudric M; Couturier D; Levy C
Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
[TBL] [Abstract][Full Text] [Related]
14. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
[TBL] [Abstract][Full Text] [Related]
15. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
Loeschke K; Abb J; Farack UM; Wiebecke B
Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
[TBL] [Abstract][Full Text] [Related]
16. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis due to hepatitis B virus.
Sherlock S; Thomas HC
Lancet; 1985 Dec; 2(8468):1343-6. PubMed ID: 2866396
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
19. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
Romeo F; Spina A; Cannaò G
Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032
[No Abstract] [Full Text] [Related]
20. Effect of vidarabine on chronic hepatitis B virus infection.
Pollard RB; Smith JL; Neal A; Gregory PB; Merigan TC; Robinson WS
JAMA; 1978 Apr; 239(16):1648-50. PubMed ID: 633577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
